The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030.
Emmanuel NdashimyeEric J ArtsPublished in: Infectious diseases of poverty (2019)
The achievement of United Nations Programme on HIV and AIDS 2020 and 2030 targets in LICs depends on access to active cART with higher genetic barrier to drug resistance, better safety, and tolerability profiles. It's also imperative to strengthen quality service delivery in terms of retention of patients to treatment, support for adherence to cART, patient follow up and adequate drug stocks to help achieve a free AIDS generation.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv positive
- hiv infected patients
- hiv aids
- end stage renal disease
- ejection fraction
- chronic kidney disease
- mental health
- newly diagnosed
- healthcare
- prognostic factors
- randomized controlled trial
- adipose tissue
- case report
- genome wide
- patient reported outcomes
- study protocol
- dna methylation
- helicobacter pylori infection
- hepatitis c virus
- south africa
- men who have sex with men
- insulin resistance
- copy number
- metabolic syndrome
- quality improvement
- placebo controlled
- skeletal muscle
- replacement therapy
- patient reported
- weight loss